# Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

> **NCT02790190** · PHASE3 · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 400 (estimated)

## Conditions studied

- Lung Neoplasms

## Interventions

- **OTHER:** Radiotherapy dose

## Key facts

- **NCT ID:** NCT02790190
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790190, "Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02790190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*